The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease

Abstract Background Exosome liquid biopsies might be a good supplement for early diagnosis of interstitial lung disease (ILD), especially those challenging cases such as connective tissue disease-ILD (CTD-ILD). Methods We developed a circulating exosomal proteomic signature to identify novel biomark...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming Dong, Gaolei Hu, Xi Chen, Lingling Zhang, Yuxiao Zhang, Yanting Fang, Shuilin Liao, Yukai Wang, Qian Li, Peiyan Zheng, Bingpeng Guo, Tinpou Lai, Qun Luo, Huimin Huang, Qian Han, Baoqing Sun
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-025-03326-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234735931326464
author Ming Dong
Gaolei Hu
Xi Chen
Lingling Zhang
Yuxiao Zhang
Yanting Fang
Shuilin Liao
Yukai Wang
Qian Li
Peiyan Zheng
Bingpeng Guo
Tinpou Lai
Qun Luo
Huimin Huang
Qian Han
Baoqing Sun
author_facet Ming Dong
Gaolei Hu
Xi Chen
Lingling Zhang
Yuxiao Zhang
Yanting Fang
Shuilin Liao
Yukai Wang
Qian Li
Peiyan Zheng
Bingpeng Guo
Tinpou Lai
Qun Luo
Huimin Huang
Qian Han
Baoqing Sun
author_sort Ming Dong
collection DOAJ
description Abstract Background Exosome liquid biopsies might be a good supplement for early diagnosis of interstitial lung disease (ILD), especially those challenging cases such as connective tissue disease-ILD (CTD-ILD). Methods We developed a circulating exosomal proteomic signature to identify novel biomarkers of ILDs combined with high-resolution CT (HRCT) examination and a new method that makes exosome testing clinically feasible. Blood-derived exosomes were extracted and characterized using a centrifugal microfluidic disc system (Exo-CMDS)-based chemiluminescence immunoassay before being subjected to proteomic analysis by mass spectrometry. Significantly differentially expressed proteins (DEPs) were identified and validated in > 600 clinical samples (collected at three hospitals) by comparing the ILD and disease/healthy control groups. Multivariable logistic regression (LR) analysis was implemented to test the diagnostic performance of the selected biomarkers either alone or in combination. Results Candidate biomarkers KL-6, CAPN2, SP-B were selected from the top DEPs. An LR model that combined exosomal KL-6/CAPN2/SP-B levels performed well in both the discovery (AUC = 0.987, 95%CI = 0.975–0.998) and validation (AUC = 0.936, 95%CI = 0.911–0.960) sets. The LR model based on the three biomarkers exhibited markedly better diagnostic performance (AUC = 0.880, 95%CI = 0.834–0.925) in serum-KL-6-negative ILD, than the conventional serum-KL-6-based method and could also accurately diagnose connective tissue disease associated-ILD (CTD-ILD) in the context of CTD. Conclusion The circulating exosomal protein detection system used in this study represents a valuable tool for identifying promising exosomal biomarkers for ILD and holds promise for improving the diagnosis and prognosis of patients with ILD in the future.
format Article
id doaj-art-f12591bcad7f47a8ab2bc76d23aed4ad
institution Kabale University
issn 1465-993X
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj-art-f12591bcad7f47a8ab2bc76d23aed4ad2025-08-20T04:03:02ZengBMCRespiratory Research1465-993X2025-08-0126111310.1186/s12931-025-03326-2The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung diseaseMing Dong0Gaolei Hu1Xi Chen2Lingling Zhang3Yuxiao Zhang4Yanting Fang5Shuilin Liao6Yukai Wang7Qian Li8Peiyan Zheng9Bingpeng Guo10Tinpou Lai11Qun Luo12Huimin Huang13Qian Han14Baoqing Sun15State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityGuangdong Province, Guangzhou National LaboratoryGuangdong Province, Guangzhou National LaboratoryState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityGuangdong Province, Guangzhou National LaboratoryDepartment of Rheumatology and Immunology, Shantou Central HospitalThe First Affiliated Hospital of Chongqing Medical and Pharmaceutical CollegeState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityGuangdong Province, Guangzhou National LaboratoryGuangdong Province, Guangzhou National LaboratoryState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Respiratory and Critical Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityGuangdong Province, Guangzhou National LaboratoryState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityAbstract Background Exosome liquid biopsies might be a good supplement for early diagnosis of interstitial lung disease (ILD), especially those challenging cases such as connective tissue disease-ILD (CTD-ILD). Methods We developed a circulating exosomal proteomic signature to identify novel biomarkers of ILDs combined with high-resolution CT (HRCT) examination and a new method that makes exosome testing clinically feasible. Blood-derived exosomes were extracted and characterized using a centrifugal microfluidic disc system (Exo-CMDS)-based chemiluminescence immunoassay before being subjected to proteomic analysis by mass spectrometry. Significantly differentially expressed proteins (DEPs) were identified and validated in > 600 clinical samples (collected at three hospitals) by comparing the ILD and disease/healthy control groups. Multivariable logistic regression (LR) analysis was implemented to test the diagnostic performance of the selected biomarkers either alone or in combination. Results Candidate biomarkers KL-6, CAPN2, SP-B were selected from the top DEPs. An LR model that combined exosomal KL-6/CAPN2/SP-B levels performed well in both the discovery (AUC = 0.987, 95%CI = 0.975–0.998) and validation (AUC = 0.936, 95%CI = 0.911–0.960) sets. The LR model based on the three biomarkers exhibited markedly better diagnostic performance (AUC = 0.880, 95%CI = 0.834–0.925) in serum-KL-6-negative ILD, than the conventional serum-KL-6-based method and could also accurately diagnose connective tissue disease associated-ILD (CTD-ILD) in the context of CTD. Conclusion The circulating exosomal protein detection system used in this study represents a valuable tool for identifying promising exosomal biomarkers for ILD and holds promise for improving the diagnosis and prognosis of patients with ILD in the future.https://doi.org/10.1186/s12931-025-03326-2Interstitial lung diseaseLiquid biopsyExosomal biomarkerKrebs von den Lungen 6
spellingShingle Ming Dong
Gaolei Hu
Xi Chen
Lingling Zhang
Yuxiao Zhang
Yanting Fang
Shuilin Liao
Yukai Wang
Qian Li
Peiyan Zheng
Bingpeng Guo
Tinpou Lai
Qun Luo
Huimin Huang
Qian Han
Baoqing Sun
The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
Respiratory Research
Interstitial lung disease
Liquid biopsy
Exosomal biomarker
Krebs von den Lungen 6
title The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
title_full The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
title_fullStr The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
title_full_unstemmed The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
title_short The exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
title_sort exosomal protein biomarkers auxiliary in diagnosis of interstitial lung disease
topic Interstitial lung disease
Liquid biopsy
Exosomal biomarker
Krebs von den Lungen 6
url https://doi.org/10.1186/s12931-025-03326-2
work_keys_str_mv AT mingdong theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT gaoleihu theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT xichen theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT linglingzhang theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT yuxiaozhang theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT yantingfang theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT shuilinliao theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT yukaiwang theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT qianli theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT peiyanzheng theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT bingpengguo theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT tinpoulai theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT qunluo theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT huiminhuang theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT qianhan theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT baoqingsun theexosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT mingdong exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT gaoleihu exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT xichen exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT linglingzhang exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT yuxiaozhang exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT yantingfang exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT shuilinliao exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT yukaiwang exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT qianli exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT peiyanzheng exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT bingpengguo exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT tinpoulai exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT qunluo exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT huiminhuang exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT qianhan exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease
AT baoqingsun exosomalproteinbiomarkersauxiliaryindiagnosisofinterstitiallungdisease